![{[setting('site_name')]}](https://www.projxnews.com/uploads/setting/16983847711140531930.webp)
Poly Medicure is aggressively scaling its operations and R&D capabilities to double its international revenue by FY30. With a planned capital expenditure of ₹296 crore in FY26, the company is prioritizing the construction of two new manufacturing facilities and the acceleration of its innovation pipeline. Having launched 35 new products this fiscal year, the company is now advancing over 50 specialized medical devices across cardiology, critical care, and oncology. By integrating backward and consolidating high-volume production in India, Poly Medicure aims to reach an export-driven revenue target of approximately ₹2,560 crore by FY30, ensuring sustained growth and robust operating margins.
News by Rahul Yelligetti.
